Familial disorders of parathyroid glands

Lori A. Erickson

Research output: Contribution to journalReview article

Abstract

The molecular mechanisms underlying familial parathyroid diseases continue to be elucidated. The mechanisms of familial parathyroid diseases are better understood than many sporadic parathyroid diseases. Familial parathyroid disease is associated with multiple endocrine neoplasia type 1 which is associated with MEN1 mutation, multiple endocrine neoplasia type 2A caused by RET mutation, and multiple endocrine neoplasia type 4 is caused with CDKN1B mutation. Sporadic parathyroid tumours are identified with mutations of MEN1 but generally not of RET. CDKN1B mutations are also identified in sporadic forms of primary hyperparathyroidism, although very rarely. Calcium sensing receptor gene mutations are involved in familial hyperparathyroidism and hypoparathyroidism, but are generally not identified in sporadic parathyroid tumours. However, the HPRT2 (CDC73) gene, which is mutated in hyperparathyroidism jaw-tumour syndrome and a subset of cases of familial isolated hyperparathyroidism, is frequently mutated in sporadic parathyroid carcinomas. Germline activating GCM2 mutations were recently found associated with a subset of familial isolated hyperparathyroidism. Parafibromin, a protein encoded by HPRT2, has been used in the diagnostic setting. The understanding and pathogenesis of parathyroid disease continues to evolve.

Original languageEnglish (US)
Pages (from-to)359-365
Number of pages7
JournalDiagnostic Histopathology
Volume23
Issue number8
DOIs
StatePublished - Aug 1 2017

Fingerprint

Parathyroid Glands
Parathyroid Diseases
Mutation
Multiple Endocrine Neoplasia Type 1
Multiple Endocrine Neoplasia Type 2a
Calcium-Sensing Receptors
Hypoparathyroidism
Parathyroid Neoplasms
Primary Hyperparathyroidism
Hyperparathyroidism
Genes
Neoplasms

Keywords

  • adenoma
  • carcinoma
  • familial hyperparathyroidism
  • hyperparathyroidism
  • hyperplasia
  • hypoparathyroidism
  • multiple endocrine neoplasia
  • parathyroid

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Familial disorders of parathyroid glands. / Erickson, Lori A.

In: Diagnostic Histopathology, Vol. 23, No. 8, 01.08.2017, p. 359-365.

Research output: Contribution to journalReview article

Erickson, Lori A. / Familial disorders of parathyroid glands. In: Diagnostic Histopathology. 2017 ; Vol. 23, No. 8. pp. 359-365.
@article{3c4f050ec5c94b75bb788379fae64312,
title = "Familial disorders of parathyroid glands",
abstract = "The molecular mechanisms underlying familial parathyroid diseases continue to be elucidated. The mechanisms of familial parathyroid diseases are better understood than many sporadic parathyroid diseases. Familial parathyroid disease is associated with multiple endocrine neoplasia type 1 which is associated with MEN1 mutation, multiple endocrine neoplasia type 2A caused by RET mutation, and multiple endocrine neoplasia type 4 is caused with CDKN1B mutation. Sporadic parathyroid tumours are identified with mutations of MEN1 but generally not of RET. CDKN1B mutations are also identified in sporadic forms of primary hyperparathyroidism, although very rarely. Calcium sensing receptor gene mutations are involved in familial hyperparathyroidism and hypoparathyroidism, but are generally not identified in sporadic parathyroid tumours. However, the HPRT2 (CDC73) gene, which is mutated in hyperparathyroidism jaw-tumour syndrome and a subset of cases of familial isolated hyperparathyroidism, is frequently mutated in sporadic parathyroid carcinomas. Germline activating GCM2 mutations were recently found associated with a subset of familial isolated hyperparathyroidism. Parafibromin, a protein encoded by HPRT2, has been used in the diagnostic setting. The understanding and pathogenesis of parathyroid disease continues to evolve.",
keywords = "adenoma, carcinoma, familial hyperparathyroidism, hyperparathyroidism, hyperplasia, hypoparathyroidism, multiple endocrine neoplasia, parathyroid",
author = "Erickson, {Lori A.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.mpdhp.2017.06.002",
language = "English (US)",
volume = "23",
pages = "359--365",
journal = "Diagnostic Histopathology",
issn = "1756-2317",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - Familial disorders of parathyroid glands

AU - Erickson, Lori A.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - The molecular mechanisms underlying familial parathyroid diseases continue to be elucidated. The mechanisms of familial parathyroid diseases are better understood than many sporadic parathyroid diseases. Familial parathyroid disease is associated with multiple endocrine neoplasia type 1 which is associated with MEN1 mutation, multiple endocrine neoplasia type 2A caused by RET mutation, and multiple endocrine neoplasia type 4 is caused with CDKN1B mutation. Sporadic parathyroid tumours are identified with mutations of MEN1 but generally not of RET. CDKN1B mutations are also identified in sporadic forms of primary hyperparathyroidism, although very rarely. Calcium sensing receptor gene mutations are involved in familial hyperparathyroidism and hypoparathyroidism, but are generally not identified in sporadic parathyroid tumours. However, the HPRT2 (CDC73) gene, which is mutated in hyperparathyroidism jaw-tumour syndrome and a subset of cases of familial isolated hyperparathyroidism, is frequently mutated in sporadic parathyroid carcinomas. Germline activating GCM2 mutations were recently found associated with a subset of familial isolated hyperparathyroidism. Parafibromin, a protein encoded by HPRT2, has been used in the diagnostic setting. The understanding and pathogenesis of parathyroid disease continues to evolve.

AB - The molecular mechanisms underlying familial parathyroid diseases continue to be elucidated. The mechanisms of familial parathyroid diseases are better understood than many sporadic parathyroid diseases. Familial parathyroid disease is associated with multiple endocrine neoplasia type 1 which is associated with MEN1 mutation, multiple endocrine neoplasia type 2A caused by RET mutation, and multiple endocrine neoplasia type 4 is caused with CDKN1B mutation. Sporadic parathyroid tumours are identified with mutations of MEN1 but generally not of RET. CDKN1B mutations are also identified in sporadic forms of primary hyperparathyroidism, although very rarely. Calcium sensing receptor gene mutations are involved in familial hyperparathyroidism and hypoparathyroidism, but are generally not identified in sporadic parathyroid tumours. However, the HPRT2 (CDC73) gene, which is mutated in hyperparathyroidism jaw-tumour syndrome and a subset of cases of familial isolated hyperparathyroidism, is frequently mutated in sporadic parathyroid carcinomas. Germline activating GCM2 mutations were recently found associated with a subset of familial isolated hyperparathyroidism. Parafibromin, a protein encoded by HPRT2, has been used in the diagnostic setting. The understanding and pathogenesis of parathyroid disease continues to evolve.

KW - adenoma

KW - carcinoma

KW - familial hyperparathyroidism

KW - hyperparathyroidism

KW - hyperplasia

KW - hypoparathyroidism

KW - multiple endocrine neoplasia

KW - parathyroid

UR - http://www.scopus.com/inward/record.url?scp=85021961824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021961824&partnerID=8YFLogxK

U2 - 10.1016/j.mpdhp.2017.06.002

DO - 10.1016/j.mpdhp.2017.06.002

M3 - Review article

VL - 23

SP - 359

EP - 365

JO - Diagnostic Histopathology

JF - Diagnostic Histopathology

SN - 1756-2317

IS - 8

ER -